{"id":634351,"date":"2026-04-27T15:47:13","date_gmt":"2026-04-27T15:47:13","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/634351\/"},"modified":"2026-04-27T15:47:13","modified_gmt":"2026-04-27T15:47:13","slug":"eli-lilly-and-companys-lly-foundayo-gets-prescribed-3707-times-in-the-us-in-second-week-of-launch-reuters-reports","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/634351\/","title":{"rendered":"Eli Lilly and Company\u2019s (LLY) Foundayo Gets Prescribed 3,707 Times in the US in Second Week of Launch, Reuters Reports"},"content":{"rendered":"\n<p class=\"yf-1fy9kyt\">Eli Lilly and Company (NYSE:<a href=\"https:\/\/finance.yahoo.com\/quote\/LLY\" data-ylk=\"slk:LLY;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;LLY&quot;}\" class=\"link \" rel=\"nofollow noopener\" target=\"_blank\">LLY<\/a>) is one of <a href=\"https:\/\/www.insidermonkey.com\/blog\/8-best-low-volatility-stocks-to-invest-in-right-now-1746306\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:the best low volatility stocks to invest in right now;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;the best low volatility stocks to invest in right now&quot;}\" class=\"link \">the best low volatility stocks to invest in right now<\/a>. On April 24, Reuters reported that, according to analysts citing IQVIA data, Eli Lilly and Company\u2019s (NYSE:LLY) newly launched oral weight loss drug, branded as Foundayo, was prescribed 3,707 times in the United States in the second week following its launch earlier in the month. The pill had 1,390 prescriptions in its first week of launch. Reuters provided additional perspective in the context of Eli Lilly and Company\u2019s (NYSE:LLY) rival Novo \u200bNordisk\u2019s Wegovy pill. It reported that Wegovy has been on the market since January and had 3,071 prescriptions in its first week, followed by 18,410 prescriptions in the second week.<\/p>\n<p>    <img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/04\/860932d32d923713fdffa5b1d444d8a3.jpeg\" alt=\"RBC Capital Sees Eli Lilly\u2019s (LLY) Retatrutide as Key Growth Driver despite Mixed Trial Results\" loading=\"eager\" height=\"538\" width=\"960\" class=\"yf-lglytj  loaded\"\/> RBC Capital Sees Eli Lilly\u2019s (LLY) Retatrutide as Key Growth Driver despite Mixed Trial Results      <\/p>\n<p class=\"yf-1fy9kyt\">RBC Capital Markets analyst Trung Huynh stated that although they believe comparisons made early into the launch \u201cshould be considered immaterial, Foundayo\u2019s uptake this week is likely to be \u200breceived negatively\u201d. Reuters also reported that J.P. Morgan analyst Chris Schott stated that the landscape represents a relatively slower ramp compared to oral Wegovy, which is not surprising, given the pill\u2019s advantages in time to market and brand \u200brecognition.<\/p>\n<p class=\"yf-1fy9kyt\">Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span oncology, diabetes, immunology, neuroscience, and other therapies.<\/p>\n<p class=\"yf-1fy9kyt\">While we acknowledge the potential of LLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you&#8217;re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the<a class=\"link \" href=\"https:\/\/www.insidermonkey.com\/blog\/three-megatrends-one-overlooked-stock-massive-upside-1548959\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:best short-term AI stock;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;best short-term AI stock&quot;}\"> best short-term AI stock<\/a>.<\/p>\n<p class=\"yf-1fy9kyt\">READ NEXT: <a class=\"link \" href=\"https:\/\/www.insidermonkey.com\/blog\/15-stocks-that-will-make-you-rich-in-10-years-1711641\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:15 Stocks That Will Make You Rich in 10 Years;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;15 Stocks That Will Make You Rich in 10 Years&quot;}\">15 Stocks That Will Make You Rich in 10 Years<\/a> AND <a class=\"link \" href=\"https:\/\/www.insidermonkey.com\/blog\/wp-admin\/post.php?post=1711060&amp;action=edit\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:12 Best Stocks That Will Always Grow;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;12 Best Stocks That Will Always Grow&quot;}\">12 Best Stocks That Will Always Grow<\/a>.<\/p>\n<p class=\"yf-1fy9kyt\">Disclosure: None. <a class=\"link \" href=\"https:\/\/news.google.com\/publications\/CAAqLQgKIidDQklTRndnTWFoTUtFV2x1YzJsa1pYSnRiMjVyWlhrdVkyOXRLQUFQAQ?hl=en-US&amp;gl=US&amp;ceid=US%3Aen\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Follow Insider Monkey on Google News;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Follow Insider Monkey on Google News&quot;}\">Follow Insider Monkey on Google News<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Eli Lilly and Company (NYSE:LLY) is one of the best low volatility stocks to invest in right now.&hellip;\n","protected":false},"author":2,"featured_media":634352,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[64,63,92143,137,490],"class_list":{"0":"post-634351","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-au","9":"tag-australia","10":"tag-eli-lilly-and-company","11":"tag-health","12":"tag-medication"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/634351","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=634351"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/634351\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/634352"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=634351"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=634351"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=634351"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}